Clinical and Translational Research
Copyright ©The Author(s) 2021.
World J Gastroenterol. Feb 21, 2021; 27(7): 609-623
Published online Feb 21, 2021. doi: 10.3748/wjg.v27.i7.609
Table 1 Participant demographics

Total (n = 145), mean ± SD (% of cohort)
NASH
NAFL
Total cohort (n)1458758
Sex (male)88 (60.7%)4642a
Age60.2 ± 13.160.9 ± 13.259 ± 12.9
BMI average28.8 ± 4.729.9 ± 4.427.1 ± 4.8c
Normal BMI (≥ 18.5 ≤ 22.9)21.4 ± 1.6 (n = 17)n = 6 n = 12
Overweight (≥ 23.0 ≤ 27.9)25.6 ± 1.1 (n = 43)n = 26 n = 26
Obese (≥ 27.5)32.1 ± 3.2 (n = 82)n = 55n = 20
Blood serum tests
AST (IU/L)47.8 ± 27.556.4 ± 29.834.8 ± 17.1c
ALT (IU/L)59.8 ± 49.371.3 ± 51.542.6 ± 41.4c
GGT85.9 ± 78.497.8 ± 85.869.3 ± 62.9b
Total bilirubin (mg/dL)0.86 ± 0.40.8 ± 0.30.9 ± 0.4
Platelets (× 104/μL)19.4 ± 7.319.9 ± 7.518.8 ± 7
HbA1C (%)6.5 ± 1.16.6 ± 1.06.5 ± 1.1
Fasting insulin (mU/mL)20 ± 14.220.6 ± 11.619 ± 17.4
Fasting blood glucose (mg/dL)124 ± 34.7126.1 ± 32.5120.8 ± 37.8
Albumin (g/dL)4.3 ± 0.54.3 ± 0.44.2 ± 0.5
Non-invasive test
cT1871 ± 102 (n = 143)907 ± 90 (n = 87)817 ± 96c (n = 56)
MR liver fat11.4 ± 6.1 (n = 143)13.6 ± 5.8 (n = 87)8.1 ± 5.1c (n = 56)
CAP294.3 ± 47.4 (n = 117)309.1 ± 37.1 (n = 74)268.9 ± 52.7c (n = 43)
VCTE-LSM12.8 ± 9.5 (n = 117)13 ± 8.4 (n = 74)12.5 ± 11.1 (n = 43)
MRE4.2 ± 1.7 (n = 144)4.3 ± 1.5 (n = 88)4.1 ± 1.9 (n = 56)
SE9.3 ± 2.7 (n = 84)9.6 ± 2.4 (n = 50)8.8 ± 3.1 (n = 33)
Reported pre-existing conditions
Hypertensiven = 71n = 45n = 26
Dyslipidaemicn = 111n = 72n = 39
Reported as diabeticn = 97n = 59n = 38

  • Citation: Imajo K, Tetlow L, Dennis A, Shumbayawonda E, Mouchti S, Kendall TJ, Fryer E, Yamanaka S, Honda Y, Kessoku T, Ogawa Y, Yoneda M, Saito S, Kelly C, Kelly MD, Banerjee R, Nakajima A. Quantitative multiparametric magnetic resonance imaging can aid non-alcoholic steatohepatitis diagnosis in a Japanese cohort. World J Gastroenterol 2021; 27(7): 609-623
  • URL: https://www.wjgnet.com/1007-9327/full/v27/i7/609.htm
  • DOI: https://dx.doi.org/10.3748/wjg.v27.i7.609